Skip to main content

Want a detailed portfolio tracker?

Kestra Medical Technologies (KMTS) Total Debt (2024 - 2026)

Kestra Medical Technologies (KMTS) total debt from Apr 30, 2024 to Jan 31, 2026. The current Kestra Medical Technologies (KMTS) total debt is $91M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Debt

Total Debt

Kestra Medical Technologies (KMTS) Total Debt CAGR table

PeriodCAGR
1 Year TTM+342.92%

Annual Total Debt change of Kestra Medical Technologies (KMTS)

YearTotal DebtChange
2025$90M
+15.49%
2024$78M
N/A

Comparison Kestra Medical Technologies (KMTS) total debt with competitors

Kestra Medical Technologies (KMTS) total debt is $91.35M.

TickerNameTotal DebtUpside
NNNNAnbio Biotechnology - Class A$87836.00-99.90%
LUCYInnovative Eyewear Inc$1.11M-98.78%
STSSSharps Technology Inc$2.22M-97.57%
RGNTRegentis Biomaterials Ltd$2.87M-96.85%
NEPHNephros Inc$3.09M-96.61%
CUPRCuprina Holdings (Cayman) Ltd - Class A$3.45M-96.22%
MBOTMicrobot Medical Inc$3.96M-95.66%
UTMDUtah Medical Products Inc$4.01M-95.61%
GCTKGlucoTrack Inc$5.01M-94.52%
ZTEKZentek Ltd$5.04M-94.48%
MLSSMilestone Scientific Inc$5.68M-93.78%
NXGLNexgel Inc$7.12M-92.21%
FEMYFemasys Inc$9.21M-89.92%
KRMDKORU Medical Systems Inc$11.67M-87.23%
POCIPrecision Optics Corp Inc$13.58M-85.13%
EKSOEkso Bionics Holdings Inc$13.93M-84.75%
PLSEPulse Biosciences Inc$15.32M-83.22%
AVRAnteris Technologies Global Corp$16.31M-82.14%
ZJYLJin Medical International Ltd$23.80M-73.95%
MHUAMeihua International Medical Technologies Co Ltd - Class A$27.26M-70.15%
BNGOBionano Genomics Inc$27.34M-70.07%
BLFSBiolife Solutions Inc$28.68M-68.61%
PDEXPro-Dex Inc (co)$29.78M-67.40%
STXSStereotaxis Inc$34.43M-62.31%
DXRDaxor Corp$49.51M-45.80%
NYXHNyxoah SA$61.96M-32.17%
SMTISanara MedTech Inc$62.26M-31.85%
OSUROrasure Technologies Inc$65.84M-27.92%
RVPRetractable Technologies Inc$67.50M-26.10%
HBIOHarvard Bioscience Inc$67.89M-25.68%
ANGOAngiodynamic Inc$87.32M-4.41%
STAAStaar Surgical Company$98.75M+8.10%
ATRCAtricure Inc$152.29M+66.72%
LMATLemaitre Vascular Inc$222.90M+144.01%
AZTAAzenta Inc$349.21M+282.28%
WRBYWarby Parker Inc - Class A$360.60M+294.75%
RGENRepligen Corp$825.31M+803.46%
STVNStevanato Group Spa$1.05B+1052.70%
MMSIMerit Medical Systems Inc$1.09B+1096.01%
WSTWest Pharmaceutical Services Inc$1.12B+1125.40%
ALGNAlign Technology Inc$2.16B+2269.74%
RMDResmed Inc$2.29B+2409.44%
ISRGIntuitive Surgical Inc$2.51B+2651.83%
TFXTeleflex Incorporated$3.70B+3948.79%
XRAYDENTSPLY Sirona Inc$3.91B+4180.24%
COOCooper Companies Inc$4.06B+4344.66%
AVTRAvantor Inc$6.07B+6549.48%
HOLXHologic Inc$7.32B+7911.65%
BLCOBausch + Lomb Corp$7.33B+7921.89%
SOLVSolventum Corp$9.13B+9892.34%
ALCAlcon Inc$9.54B+10340.83%
BAXBaxter International Inc$13.83B+15039.57%